Friday, December 19, 2014

Biotechs provide critical link to innovations for Pharma companies

Innovation in the life science industry is evolving.  With over 90% of innovations occuring outside of big Pharma's research and development labs, it's important that big pharma be in tuned with what's going on in and leverage the expertise across the value chain.  In a recent interview at partnering 360®, Jochen Maas, the General Manager of Research and Development at Sanofi Germany sat down and shared his thoughts on capitalizing on external innovation with partners and identifying the real experts in the Pharma and Biotech industry to get products to the patients as fast as possible.

Watch the interview here:

Partnering with experts in the field a company trying to excel in - especially Pharma and Biotech - is critical. What do you see are the benefits of working with the innovative biotech industry for clinical trials?

This April at Partnerships in Clinical Trials, Annalisa Jenkins, Dimension Therapeutics will join us at a session to look further into opportunities for innovation within the biotech sector. Would you like to join her April 22-24 in Boston? As a reader of this blog, you can register to join us with code XP2000BL and save $100 off current rates. Or you can enter for a chance to win a free pass when you retweet this tweet!




No comments: